Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis
YT Kuo, JM Liou, EM El-Omar, JY Wu… - The Lancet …, 2017 - thelancet.com
Background So far, a comprehensive systematic review and meta-analysis has not been
done of the prevalence of primary antibiotic resistance in Helicobacter pylori in the Asia …
done of the prevalence of primary antibiotic resistance in Helicobacter pylori in the Asia …
Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance
Y Hu, Y Zhu, NH Lu - Frontiers in cellular and infection microbiology, 2017 - frontiersin.org
Helicobacter pylori (H. pylori) is a common gastrointestinal bacterial strain closely
associated with the incidence of chronic gastritis, peptic ulcers, gastric mucosa-associated …
associated with the incidence of chronic gastritis, peptic ulcers, gastric mucosa-associated …
ACG clinical guideline: treatment of Helicobacter pylori infection
Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important
cause of peptic ulcer disease and gastric cancer. H. pylorimay also have a role in …
cause of peptic ulcer disease and gastric cancer. H. pylorimay also have a role in …
Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report
P Malfertheiner, F Mégraud, CA O'Morain, JP Gisbert… - Gut, 2017 - gut.bmj.com
Important progress has been made in the management of Helicobacter pylori infection and
in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role …
in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role …
Joint ESPGHAN/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents (update 2016)
NL Jones, S Koletzko, K Goodman… - Journal of pediatric …, 2017 - journals.lww.com
Background: Because of the changing epidemiology of Helicobacter pylori infection and low
efficacy of currently recommended therapies, an update of the European Society for …
efficacy of currently recommended therapies, an update of the European Society for …
Population screening and treatment of Helicobacter pylori infection
A O'connor, CA O'morain, AC Ford - Nature Reviews Gastroenterology & …, 2017 - nature.com
Helicobacter pylori is an important human pathogen, associated with a substantial burden
from both malignant and non-malignant diseases. The bacterium is classed as a human …
from both malignant and non-malignant diseases. The bacterium is classed as a human …
Systematic review with meta‐analysis: the efficacy of vonoprazan‐based triple therapy on Helicobacter pylori eradication
YS Jung, EH Kim, CH Park - Alimentary Pharmacology & …, 2017 - Wiley Online Library
Background In order to increase eradication rates, vonoprazan, a novel potassium‐
competitive acid blocker, has been used in Helicobacter pylori eradication therapy. Aim To …
competitive acid blocker, has been used in Helicobacter pylori eradication therapy. Aim To …
Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies
JP Gisbert, AG McNicholl - Helicobacter, 2017 - Wiley Online Library
Background As with any other infectious disease, we should aim for treatments offering≥
90% Helicobacter pylori eradication rates in clinical practice. Aim To summarize optimization …
90% Helicobacter pylori eradication rates in clinical practice. Aim To summarize optimization …
VI национальные рекомендации по диагностике и лечению кислотозависимых и ассоциированных с Helicobacter pylori заболеваний (VI Московские …
ЛБ Лазебник, ЕИ Ткаченко… - Экспериментальная …, 2017 - cyberleninka.ru
VI национальные рекомендации по диагностике и лечению кислотозависимых и
ассоциированных с Helicobacter pylori заболеваний (VI московские соглашения) – тема …
ассоциированных с Helicobacter pylori заболеваний (VI московские соглашения) – тема …
Primary Antibiotic Resistance of Helicobacter pylori in China
Y Hu, Y Zhu, N Lu - Digestive diseases and sciences, 2017 - Springer
Abstract Background and Aims Antibiotic resistance is the most important factor leading to
the failure of eradication regimens; thus, it is important to obtain regional antibiotic …
the failure of eradication regimens; thus, it is important to obtain regional antibiotic …